Zydus Lifesciences gets FDA approval for Ivermectin Cream, 1%
Zydus Lifesciences (previously called Cadila Healthcare) has secured final approval for antiparasitic ointment Ivermectin Cream, 1% from the US Food and Drug Administration (FDA). Ivermectin Cream, 1% is the generic of Soolantra, which is used for treating inflammatory lesions of rosacea. Zydus Lifesciences will manufacture Ivermectin Cream at its topical manufacturing facility in Ahmedabad, India. […]